Prevnar

Showing 5 posts of 5 posts found.

pfizer_reflection

Revenue rises at Pfizer as Ibrance and Xeljanz beat sales expectations

August 2, 2016
Research and Development, Sales and Marketing 2016, Pfizer, Prevnar, Q2, Xeljanz, ibrance, results

Pfizer has published its Q2 results, which show revenues rising 11% with new drugs helping to drive the growth and …

Pfizer image

Lipitor competition holds Pfizer back

July 31, 2013
Sales and Marketing Lipitor, Pfizer, Prevnar, Q2

Pfizer’s revenues in the second quarter of 2013 fell 7% year-on-year, in part due to the loss of patent in …

Pfizer stumbles in third quarter

November 2, 2012
Research and Development, Sales and Marketing Ian Read, Lipitor, Pfizer, Prevnar, Q3

Pfizer has experienced a worse than expected third quarter, due to disappointing sales of paediatric vaccine Prevnar and a surprise …

Lipitor loss continues to hit Pfizer sales

July 31, 2012
Sales and Marketing Enbrel, Lipitor, Pfizer, Prevnar, Q2

Pfizer has posted a loss in revenue for the second quarter as the firm continues to feel the impact of …

pfizer_hq_street_web

Prevnar and Lyrica lift Pfizer results

November 1, 2011
Research and Development, Sales and Marketing Lipitor, Lyrica, Pfizer, Prevnar, patent expiry

Strong sales of Lyrica and its Prevnar vaccines coupled with favourable exchange rates have helped Pfizer deliver a strong quarter.  …

The Gateway to Local Adoption Series

Latest content